Your browser doesn't support javascript.
loading
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.
Tiribelli, Mario; Binotto, Gianni; Calistri, Elisabetta; Maino, Elena; Scaffidi, Luigi; Medeot, Marta; Nabergoj, Mitja; Ambrosetti, Achille; Semenzato, Gianpietro; Fanin, Renato; Bonifacio, Massimiliano.
Affiliation
  • Tiribelli M; Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria, Udine, Italy.
  • Binotto G; Padua School of Medicine, Department of Medicine, Hematology and Clinical Immunology, Padua, Italy.
  • Calistri E; Division of Hematology, Ca' Foncello Hospital, Treviso, Italy.
  • Maino E; Division of Hematology, Dell'angelo Hospital, Venezia-Mestre, Italy.
  • Scaffidi L; Department of Medicine, Section of Hematology, University of Verona, Italy.
  • Medeot M; Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria, Udine, Italy.
  • Nabergoj M; Padua School of Medicine, Department of Medicine, Hematology and Clinical Immunology, Padua, Italy.
  • Ambrosetti A; Department of Medicine, Section of Hematology, University of Verona, Italy.
  • Semenzato G; Padua School of Medicine, Department of Medicine, Hematology and Clinical Immunology, Padua, Italy.
  • Fanin R; Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria, Udine, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Italy.
Am J Hematol ; 90(7): E135-7, 2015 Jul.
Article in En | MEDLINE | ID: mdl-25808917
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / RNA, Messenger / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2015 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / RNA, Messenger / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2015 Document type: Article Affiliation country: Italy